Overview
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
Status:
Withdrawn
Withdrawn
Trial end date:
2020-04-08
2020-04-08
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study aims to describe the changes in Levothyroxine dosage requirements in patients with hypothyroidism started on enteral feeding, and assess whether giving levothyroxine on empty stomach affects the mean percentage increase expected in Levothyroxine dosage in these patients.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Jocelyne KaramCollaborator:
Maimonides Medical Center
Criteria
Inclusion Criteria:- Adults admitted to Maimonides Medical Center
- Started on Enteral feeding within 3 days of enrollment: tube feeding, Percutaneous
Endoscopic Gastrostomy or PEG tube feeding, or Jejunostomy tube feeding.
- History of Hypothyroidism on a stable dose of Levothyroxine for at least four weeks
prior to enteral feeding
- TSH 0.2-10 mIU/ml at enrollment
Exclusion Criteria:
- Concomitant administration of medications that affect thyroid function test including
Cholestyramine, Sucralfate, Amiodarone, Lithium, Dopamine, Dobutamine and Dilantin at
enrollment.
- Pregnancy
- Known untreated disease or surgery of the small intestine specifically the Jejenum.